Related Experiment Video
Updated: Jan 24, 2026

Building Up a High-throughput Screening Platform to Assess the Heterogeneity of HER2 Gene Amplification in Breast Cancers
Published on: December 5, 2017
Publisher Correction: Clonal replacement and heterogeneity in breast tumors treated with neoadjuvant HER2-targeted
Jennifer L Caswell-Jin1, Katherine McNamara1,2,3, Johannes G Reiter4
1Department of Medicine, Division of Oncology, Stanford University School of Medicine, Stanford, 94305, California, United States.
Abstract:
The original version of this Article omitted from the Author Contributions statement that 'R.S. and J.G.R contributed equally to this work.' This has been corrected in both the PDF and HTML versions of the Article.
Related Concept Videos
Continuous Renal Replacement Therapy
Targeted Cancer Therapies
There are several types of targeted therapies against...
Extracorporeal Removal of Drugs: Continuous Renal Replacement Therapy
Treating Helicobacter pylori in Peptic Ulcers: Antimicrobial Therapy
Distance Corrections
Power Factor Correction

